UPLC-QTOF-MS/MS and Bioinformatics Association Analysis Reveals the Pharmacodynamic Flavonoids in Scutellaria barbata and the Underlying Anti-Colorectal Cancer Mechanism

被引：0
作者：
Cheng Y.-J. [1 ,2 ]
Du X.-Y. [2 ]
Chen R.-H. [1 ]
Xu J.-Y. [2 ]
Zhu A.-G. [1 ]
Jiang B. [2 ]
Tian X. [1 ]
机构：
[1] Department of Pharmacy, Changshu No.1 People’s Hospital, Changshu Hospital Affiliated to Soochow University, Changshu
[2] School of Biology and Food Engineering, Changshu Institute of Technology, Changshu
来源：
American Journal of Biochemistry and Biotechnology | 2023年 / 19卷 / 04期
基金：
中国国家自然科学基金;
关键词：
Bioinformatics Analysis; Colorectal Cancer; PI3K-Akt Signaling Pathway; Scutellaria barbata; UPLC-QTOF-MS/MS;
D O I：
10.3844/ajbbsp.2023.298.320
中图分类号：
学科分类号：
摘要：
Colorectal Cancer (CRC) is one of the most common and deadly malignancies worldwide, with no safe and effective drugs. The flavonoid in Scutellaria Barbata D. Don (SB) showed a good therapeutic effect on CRC. However, the pharmacodynamic substances and underlying mechanisms have not been elucidated which limited its development and application. This study aimed to identify the main flavonoid in SB and explore the underlying mechanism. A total of 10 flavonoid aglycones identified by UPLC-QTOFMS/MS were screened out as candidate compounds with good drug-likeness. By using the predicted targets of candidate compounds for CRC treatment, KEGG pathway analysis enriched 5 CRC-related pathways. Further analysis revealed that targets mapped to the five selected pathways were mainly correlated to the PI3K-Akt signaling pathway. The key targets were AKT1, VEGFA, EGFR, SRC, and MTOR. Molecular docking combined with the RNA sequencing analysis on CRC patients validated the high potential binding ability of candidate compounds to differentially expressed targets in the PI3KAkt signaling pathway. Collectively, this study revealed that the flavonoid aglycones in SB may be the key ingredients contributing to its CRC treatment function and they exerted the CRC treatment effect by synergistic effect of multiple targets mainly belonging to the PI3K-Akt signaling pathway. © 2023 Yi-Jie Cheng, Xin-Yun Du, Rui-Huan Chen, Jing-Yuan Xu, Ai-Guo Zhu, Bo Jiang and Xia Tian.
引用
收藏
页码：298 / 320
页数：22
相关论文
共 77 条
[1]  
Abaza M. S. I., Orabi K. Y., Al-Quattan E., AlAttiyah R. J., Growth inhibitory and chemosensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer, Cancer Cell International, 15, (2015)
[2]  
An H. J., Park M., Kim J., Han. Y. H., miR-5191 functions as a tumor suppressor by targeting RPS6KB1 in colorectal cancer, International Journal of Oncology, 55, 4, pp. 960-972, (2019)
[3]  
Ashkenazi A., Fairbrother W. J., Leverson J. D., Souers A. J., From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors, Nature Reviews. Drug Discovery, 16, 4, pp. 273-284, (2017)
[4]  
Aungst B. J., Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options, Journal of Pharmaceutical Sciences, 106, 4, pp. 921-929, (2017)
[5]  
Bi Y., Han X., Lai Y., Fu Y., Li K., Zhang W., Wang Q., Jiang X., Zhou Y., Liang H., Fan H., Systems pharmacological study based on UHPLC-QOrbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis, Journal of Ethnopharmacology, 278, (2021)
[6]  
Biller L. H., Schrag D., Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review, JAMA, 325, 7, pp. 669-685, (2021)
[7]  
Cartwright T. H., Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer, Clinical Colorectal Cancer, 11, 3, pp. 155-166, (2012)
[8]  
Chen D., Zhao J., Cong W., Chinese Herbal Medicines Facilitate the Control of ChemotherapyInduced Side Effects in Colorectal Cancer: Progress and Perspective, Frontiers in Pharmacology, 9, (2018)
[9]  
Chen P. Y., Tien H. J., Chen S. F., Horng C. T., Tang H. L., Jung H. L., Wu M. J., Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein, International Journal of Molecular Sciences, 19, 4, (2018)
[10]  
Chen X., Cui L., Duan X., Ma B., Zhong D., Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration, Drug Metabolism and Disposition: The Biological Fate of Chemicals, 34, 8, pp. 1345-1352, (2006)
12345678